Wei Wei

10PUBLICATIONS
61CO-AUTHORS
Predictive and prognostic markersStochastic analysis and modellingPlanning and decision makingGene and molecular therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 15, 2026
LEAD-ONC: A Platform for Reconstructing Survival Data From Trial Reports for Targeted Evidence Synthesis and Clinical Trial Design.

|Feb 11, 2025
Statistical considerations for evaluating treatment effect under various non-proportional hazard scenarios.

Xinyu Zhang, Erich J Greene, Ondrej Blaha

|Jun 26, 2024
Propensity score weighted multi-source exchangeability models for incorporating external control data in randomized clinical trials.

Wei Wei, Yunxuan Zhang, Satrajit Roychoudhury

|Apr 10, 2024
A Bayesian platform trial design with hybrid control based on multisource exchangeability modelling.

Wei Wei, Ondrej Blaha, Denise Esserman

|Aug 03, 2023
A Phase II Trial of the CD40 Agonistic Antibody Sotigalimab (APX005M) in Combination with Nivolumab in Subjects with Metastatic Melanoma with Confirmed Disease Progression on Anti-PD-1 Therapy.

Sarah A Weiss, Mario Sznol, Montaser Shaheen

|Jun 30, 2023
Quantitative DNA Repair Biomarkers and Immune Profiling for Temozolomide and Olaparib in Metastatic Colorectal Cancer.

Michael Cecchini, Janie Y Zhang, Wei Wei

Pageof 2

Frequent Collaborators

3 joint publications

Denise Esserman

2 joint publications

Satrajit Roychoudhury

2 joint publications

Patricia LoRusso

2 joint publications

Kurt A Schalper